Diagnosis and Treatment of Atrial Fibrillation
The number of people living with atrial fibrillation (AF) is increasing, and they have a higher rate of cardiovascular events, chronic kidney disease, and dementia compared with people without AF. Eme...
16 Joulu 202423min
Allogeneic Stem Cell Donation
Allogeneic stem cell transplantation is a potentially life-saving therapy for some patients with hematologic and bone marrow cancers and certain nonmalignant conditions such as sickle cell disease. He...
11 Joulu 202414min
JAMA Research at Critical Care Reviews 2024 (CCR Down Under)
JAMA Senior Editor Derek Angus, MD, MPH, and JAMA Associate Editor Christopher Seymour, MD, MSc, discuss 4 critical care trials published in JAMA and simultaneously presented at the 2024 CCR Down Unde...
11 Joulu 202417min
Loss of Obstetric Care in Rural and Urban Hospitals in the US
Access to obstetric care in US hospitals has been declining, while maternal mortality is on the rise. A new research letter published in JAMA quantifies losses and gains of obstetric care at rural and...
4 Joulu 202413min
Ovarian Aging
Ovarian aging is an important cause of infertility in women older than 35 years. Success rates of fertility treatment decline with age, most commonly due to declining ovarian function. Author Albert L...
26 Marras 202413min
Mpox Treatment Strategies, Clinical Presentation, and Diagnostic Approaches
Mpox is an evolving global health threat, and clinicians should be aware of characteristic signs and symptoms to ensure timely diagnosis and appropriate management. Author Jason Zucker, MD, MS, of Col...
19 Marras 202416min
Calcific Aortic Stenosis: Symptoms, Diagnosis, and Treatment
Calcific aortic stenosis affects approximately 12% of people >75 years in the US and worldwide leads to more than 100 000 deaths each year. Catherine M. Otto, MD, PhD, of the University of Washington ...
11 Marras 202419min
CAR T Cells and T-Cell Therapies for Cancer
CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, ...
4 Marras 202418min
